Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02552888 · ClinicalTrials.gov registry record · Phase 2
Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) Trial
A Phase 2 study, sponsored by Tulane University.
- Completed
- Registry status
- Phase 2
- Development phase
- 70
- Enrollment target
NCT02552888 is a Phase 2 study that has completed, run by Tulane University. The registered enrollment target is 70 participants.
The verdict
NCT02552888, a Phase 2 study, has completed, sponsored by Tulane University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 70 participants
- Enrollment target
Study Summary
The proposed randomized controlled trial will test the safety and efficacy of combination therapy with sodium nitrite and isoquercetin on endothelial function and inflammation among patients with chronic kidney disease.
Interventions
- DRUG Immediate release sodium nitrite
- DIETARY_SUPPLEMENT Isoquercetin
- OTHER placebos
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2016-03 |
| Est. Completion | 2017-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02552888
The ClinicalTrials.gov registry entry for NCT02552888 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Tulane University, which has 73 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Immediate release sodium nitrite is the first listed.
NCT02552888 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02552888 about?
NCT02552888 is a clinical study titled "Nitrite, Isoquercetin and Endothelial Dysfunction (NICE) Trial". The proposed randomized controlled trial will test the safety and efficacy of combination therapy with sodium nitrite and isoquercetin on endothelial function and inflammation among patients with chronic kidney disease.
What is the current status of trial NCT02552888?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 70 participants. The study started on 2016-03. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02552888?
The interventions under investigation include: Immediate release sodium nitrite (DRUG), Isoquercetin (DIETARY_SUPPLEMENT), placebos (OTHER).
Who is sponsoring clinical trial NCT02552888?
This trial is sponsored by Tulane University, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.